Page 3 - Study Chair News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Study Chair. Real-time updates on events, politics, business and more.

Praxis Bioresearch Awarded $2.9 Million Fast-Track SBIR Grant for Development of Novel Therapy ...

August 5, 2021

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Sandeep Patil Trudi Ross Jacobo Mintzer Praxis Bioresearch National Institutes Of Health Carolina Institute For Brain Health

Source: apnews.com

Peter MacCallum Cancer Centre : Improving pain relief for patients with advanced cancers

June 10, 2021

A trans-national clinical trial, involving Peter Mac patients, has found stereotactic ablative body radiation therapy provides superior relief from painful spinal lesions than standard...

Arjun Sahgal Shankar Siva Peter Mac National Health Trans Tasman Radiation Oncology Group Cancer Ablation Program

Source: marketscreener.com

Lineage Cell Therapeutics : to Host Webinar With Therapeutic Area Experts to Discuss Retinal Tissue Restoration Observed in Dry AMD Patients Treated With OpRegen®

June 3, 2021

Webinar Scheduled for June 10, 2021 at 4pm Eastern Time / 1pm Pacific Time ... | June 3, 2021

Wills Eye Hospital United States Nuevo Leóx Harvard University University Of Cincinnati Hebrew University

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Page 3 - Study Chair News Today

Praxis Bioresearch Awarded $2.9 Million Fast-Track SBIR Grant for Development of Novel Therapy ...

Peter MacCallum Cancer Centre&#xA0;: Improving pain relief for patients with advanced cancers

Lineage Cell Therapeutics&#xA0;: to Host Webinar With Therapeutic Area Experts to Discuss Retinal Tissue Restoration Observed in Dry AMD Patients Treated With OpRegen&#xAE;

Explore More Categories

Peter MacCallum Cancer Centre : Improving pain relief for patients with advanced cancers

Lineage Cell Therapeutics : to Host Webinar With Therapeutic Area Experts to Discuss Retinal Tissue Restoration Observed in Dry AMD Patients Treated With OpRegen®